![The European Institute of Innovation and Technology (EIT) announces winners of the 2018 EIT Awards on 10th anniversary - Business Review The European Institute of Innovation and Technology (EIT) announces winners of the 2018 EIT Awards on 10th anniversary - Business Review](https://business-review.eu/wp-content/uploads/2018/10/Winners.jpg)
The European Institute of Innovation and Technology (EIT) announces winners of the 2018 EIT Awards on 10th anniversary - Business Review
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
Impact Hub Zürich - Ioannis Tarnanas is Impact Hub Fellow on Healthy Living. frederike asael photography | Facebook
![EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health](https://eithealth.eu/wp-content/uploads/2019/08/EIT-Health-wins-3-of-5-top-European-awards-for-innovations-to-treat-cancer-predict-Alzheimer%E2%80%99s-and-detect-stroke-risk.jpg)
EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health
![GBHI Team Receive Multiple Awards for Driving Progress in Dementia Prevention and Care | Global Brain Health Institute GBHI Team Receive Multiple Awards for Driving Progress in Dementia Prevention and Care | Global Brain Health Institute](https://www.gbhi.org/sites/default/files/images/2020-09/warren-wong-kMRMcUcO81M-unsplash.jpg)
GBHI Team Receive Multiple Awards for Driving Progress in Dementia Prevention and Care | Global Brain Health Institute
![Altoida Awarded FDA Breakthrough Designation for Development of World's First Precision Neurology Device for Prediction of Alzheimer's Disease Altoida Awarded FDA Breakthrough Designation for Development of World's First Precision Neurology Device for Prediction of Alzheimer's Disease](http://ww1.prweb.com/prfiles/2021/07/26/18094062/logo-large.png)
Altoida Awarded FDA Breakthrough Designation for Development of World's First Precision Neurology Device for Prediction of Alzheimer's Disease
![Sabine Schumann on Twitter: Sabine Schumann on Twitter:](https://pbs.twimg.com/media/DorSTSCX4AElyZv.jpg:large)